Join us on May 7, 2025 at noon for a McGill Cares webcast to support informal caregivers./dementiaCategory: McGill Centre for Studies in Aging
Medicine and Health Sciences
Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...
Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation...
This year's Victor Dzau and Ruth Cooper-Dzau Distinguished Lecture in Global and Population Health will feature Mr. Ali Zaidi, former United States National Climate Advisor and renowned expert on...
RSS